Sydney Heart Team Logo

Industry Updates

Research

Heart, Lung and Circulation Five-year Survival of Transcatheter Aortic Valve Implantation (TAVI) in High-risk Patients

The five-year survival data of our single-institution program represents the largest long-term study of survival following TAVI in Australasia to date. ACCESS THE ARTICLE STUDY DESIGN All patients undergoing TAVI at a single tertiary institution between September 2009 and December 2015 were included. The primary outcome was survival, by linkage of patients with the National […]

Research, Special Reports

TAVI Treatment for Aortic Stenosis – World Leading Results

In an elderly high-risk population with aortic stenosis, our TAVI program reports a 30-day and 17-month mortality of 3% and 8%, respectively. These clinical outcomes are remarkable when compared with international benchmarks. For example, in contrast to our results, the French National registry of over 3000 patients (FRANCE 2 Registry) reported 30-day and 12-month mortality of 9.7% and […]

Special Reports

Medicare Benefits Schedule (MBS) for Transcatheter Mitral Valve Repair (TMVR) with the Mitraclip Device

Transcatheter mitral valve repair (TMVr) with the MitraClip device is an increasingly important part of the clinical armamentarium for treatment of mitral regurgitation (MR). TMVr provides significant quality of life and prognostic benefits in patients with functional MR who remain symptomatic despite optimal medical therapy. Furthermore, TMVr is an important treatment option in patients with […]

Sydney Heart Team Logo
Since 2009, the Sydney Heart Team has been successfully treating some of the country’s most challenging heart patients, returning them to an excellent quality of life.

- Professor Martin Ng

Stay up to date

Subscribe to our newsletter to receive industry and clinic updates. Click to view past issues.

© 2025 Sydney Heart Team Pty Ltd